Evidence map›Paper›PMID 31423055›Full record

ArticleIndian journal of nephrology

Reset Osmostat: Facts and Controversies.

J Feder, J M Gomez, F Serra-Aguirre, C G Musso

Abstract read
In one paragraph

Article in Indian journal of nephrology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Hyponatremia and malnutrition: a comprehensive review.Irish journal of medical science · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. The "new normal" osmotic threshold: Osmostat reset.Clinical nephrology. Case studies · 2022
    Article
  14. Observational
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J FederDepartment of Physiology, University Institute of Hospital Italiano de Buenos Aires, Argentina.
J M GomezDepartment of Physiology, University Institute of Hospital Italiano de Buenos Aires, Argentina.
F Serra-AguirreDepartment of Physiology, University Institute of Hospital Italiano de Buenos Aires, Argentina.
C G MussoDepartment of Physiology, University Institute of Hospital Italiano de Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reset osmostat (RO) consists of a change in the normal plasma osmolality threshold (reduction or increase), which consequently induces chronic dysnatremia (hyponatremia or hypernatremia). Although the early papers on RO state that hyponatremic patients with this condition are usually not symptomatic, the current view is that most patients with hyponatremia are symptomatic and should be treated. RO has been associated with a myriad of clinical conditions and has clear diagnostic criteria which are crucial to arrive at the correct diagnosis and treatment.

Indexed as

Hypernatremiahyponatremiareset osmostat

Identifiers

PMID31423055
PMCPMC6668321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.